These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35547369)

  • 1. A Color-Picture Version of Boston Naming Test Outperformed the Black-and-White Version in Discriminating Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    Li D; Yu YY; Hu N; Zhang M; Liu L; Fan LM; Ruan SS; Wang F
    Front Neurol; 2022; 13():884460. PubMed ID: 35547369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Composite Indices of the Color-Picture Version of Boston Naming Test Have Better Discriminatory Power: Reliability and Validity in a Chinese Sample with Diverse Neurodegenerative Diseases.
    Li D; Yu YY; Hu N; Zhang M; Sun FL; Liu L; Fan LM; Ruan SS; Wang F; Rosa-Neto P
    J Alzheimers Dis; 2023; 94(1):393-404. PubMed ID: 37248898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Thai version of the short Boston Naming Test (T-BNT) in patients with Alzheimer's dementia and mild cognitive impairment: clinical and biomarker correlates.
    Aniwattanapong D; Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Tawankanjanachot I; Chuchuen P; Snabboon T; Carvalho AF; Maes M
    Aging Ment Health; 2019 Jul; 23(7):840-850. PubMed ID: 30351202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Danish adaptation of the Boston Naming Test: preliminary norms for older adults and validity in mild Alzheimer's disease.
    Jørgensen K; Johannsen P; Vogel A
    Clin Neuropsychol; 2017; 31(sup1):72-87. PubMed ID: 28854839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical naming errors in mild cognitive impairment: A semantic deficit?
    Willers IF; Feldman ML; Allegri RF
    Dement Neuropsychol; 2008; 2(3):217-222. PubMed ID: 29213574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picture-naming test for a linguistically diverse population with cognitive impairment and dementia.
    Paplikar A; Varghese F; Alladi S; Vandana VP; Darshini KJ; Iyer GK; Kandukuri R; Divyaraj G; Sharma M; Dhaliwal RS; Kaul S; Saroja AO; Ghosh A; Sunitha J; Khan AB; Mathew R; Mekala S; Menon R; Nandi R; Narayanan J; Nehra A; Padma MV; Pauranik A; Ramakrishnan S; Sarath L; Shah U; Tripathi M; Sylaja PN; Varma RP; Verma M; Vishwanath Y;
    Int J Lang Commun Disord; 2022 Jul; 57(4):881-894. PubMed ID: 35522006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic accuracy of an incidental memory modification of the Boston Naming Test (memo-BNT) in differentiating between normal aging and mild Alzheimer's disease.
    Karrasch M; Myllyniemi A; Latvasalo L; Söderholm C; Ellfolk U; Laine M
    Clin Neuropsychol; 2010 Nov; 24(8):1355-64. PubMed ID: 20967687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Exploration of the Auditory Naming Test in Patients with Dementia.
    Hirsch JA; Cuesta GM; Fonzetti P; Comaty J; Jordan BD; Cirio R; Levin L; Abrahams A; Fry KM
    J Alzheimers Dis; 2021; 81(4):1763-1779. PubMed ID: 33998546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.
    Peng GP; Feng Z; He FP; Chen ZQ; Liu XY; Liu P; Luo BY
    CNS Neurosci Ther; 2015 Jan; 21(1):15-22. PubMed ID: 25146658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 30-item and 15-item Boston naming test Czech version: Item response analysis and normative values for healthy older adults.
    Bezdicek O; Rosická AM; Mana J; Libon DJ; Kopeček M; Georgi H
    J Clin Exp Neuropsychol; 2021 Nov; 43(9):890-905. PubMed ID: 35125051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boston Naming Test: shortened versions for use in Alzheimer's disease.
    Mack WJ; Freed DM; Williams BW; Henderson VW
    J Gerontol; 1992 May; 47(3):P154-8. PubMed ID: 1573197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12-item version of Boston Naming Test: usefulness in the diagnosis of primary progressive aphasia, frontotemporal dementia, and Alzheimer's disease.
    Graviotto HG; Sorbara MG; Rodriguez CMT; Serrano C
    Dement Neuropsychol; 2022; 16(2):181-186. PubMed ID: 35720650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative Comparison of Semantic Memory Impairment in Patients with Amnestic Mild Cognitive Impairment Based on β-Amyloid Status.
    Kim JE; Park SH; Hong YJ; Hwang J; Han NE; Lee SM; Roh JH; Kim JS; Lee JH
    J Clin Neurol; 2019 Jan; 15(1):27-37. PubMed ID: 30375759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption?
    Balthazar ML; Cendes F; Damasceno BP
    Neuropsychology; 2008 Nov; 22(6):703-9. PubMed ID: 18999343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility Study of the Boston Naming Test for the Arab Population.
    Basura HA; Mudarris M; Almubarak FB; Alzahrani SA; Alghamdi H; Alsulami A; Alnakhli A; Alzahrani G; Tayeb HO
    Cureus; 2024 Jan; 16(1):e52351. PubMed ID: 38234393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lexical semantic memory in amnestic mild cognitive impairment and mild Alzheimer's disease.
    Balthazar ML; Martinelli JE; Cendes F; Damasceno BP
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):619-22. PubMed ID: 17876402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct and Concurrent Validity of the Spanish Adaptation of the Boston Naming Test.
    Fernández AL; Fulbright RL
    Appl Neuropsychol Adult; 2015; 22(5):355-62. PubMed ID: 25668293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Chinese version of the memory binding test for distinguishing amnestic mild cognitive impairment from cognitively normal elderly individuals.
    Wang X; Li T; Zhang H; Sun T; Xiong L; Zhang Y; Sun Z; Yu X; Wang H
    Int Psychogeriatr; 2019 Dec; 31(12):1721-1730. PubMed ID: 31658921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, cognitive characteristics, and influencing factors of amnestic mild cognitive impairment among older adults residing in an urban community in Chengdu, China.
    Rao S; Cai Y; Zhong Z; Gou T; Wang Y; Liao S; Qiu P; Kuang W
    Front Neurol; 2024; 15():1336385. PubMed ID: 38356893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confrontation naming errors in Alzheimer's disease.
    Lin CY; Chen TB; Lin KN; Yeh YC; Chen WT; Wang KS; Wang PN
    Dement Geriatr Cogn Disord; 2014; 37(1-2):86-94. PubMed ID: 24107364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.